Elevated levels of cyclooxygenase-2 in antigen-stimulated mast cells is associated with minimal activation of p38 mitogen-activated protein kinase

J Immunol. 2001 Aug 1;167(3):1629-36. doi: 10.4049/jimmunol.167.3.1629.

Abstract

We have investigated possible factors that underlie changes in the production of eicosanoids after prolonged exposure of mast cells to Ag. Ag stimulation of cultured RBL-2H3 mast cells resulted in increased expression of cyclooxygenase (COX-2) protein and message. Other eicosanoid-related enzymes, namely COX-1, 5-lipoxygenase, and cytosolic phospholipase A(2) were not induced. Activation of extracellular signal-regulated kinase, c-Jun N-terminal kinase, and p38 mitogen-activated protein (MAP) kinase preceded the induction of COX-2, whereas phosphatidylinositol 3' kinase and its substrate, Akt, were constitutively activated in RBL-2H3 cells. Studies with pharmacologic inhibitors indicated that of these kinases, only p38 MAP kinase regulated expression of COX-2. The induction of COX-2 was blocked by the p38 MAP kinase inhibitor SB202190, even when added 12-16 h after stimulation with Ag when p38 MAP kinase activity had returned to near basal, but still minimally elevated, levels. Interestingly, expression of COX-2 as well as cytosolic phospholipase A(2) and 5-lipoxygenase were markedly reduced by SB202190 in unstimulated cells. Collectively, the results imply that p38 MAP kinase regulates expression of eicosanoid-related enzymes, passively or actively, at very low levels of activity in RBL-2H3 cells. Also, comparison with published data suggest that different MAP kinases regulate induction of COX-2 in inflammatory cells of different and even similar phenotype and suggest caution in extrapolating results from one type of cell to another.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antigens / immunology*
  • Arachidonate 5-Lipoxygenase / biosynthesis
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Dexamethasone / pharmacology
  • Dinitrophenols / immunology
  • Dose-Response Relationship, Immunologic
  • Enzyme Activation / immunology
  • Enzyme Induction / immunology
  • Enzyme Inhibitors / pharmacology
  • Imidazoles / pharmacology
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / biosynthesis*
  • JNK Mitogen-Activated Protein Kinases
  • Lipoxygenase Inhibitors
  • MAP Kinase Signaling System / immunology
  • Mast Cells / drug effects
  • Mast Cells / enzymology*
  • Mast Cells / immunology*
  • Membrane Proteins
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / metabolism*
  • Mitogen-Activated Protein Kinases / physiology
  • Phospholipases A / antagonists & inhibitors
  • Phospholipases A / biosynthesis
  • Phosphorylation
  • Prostaglandin-Endoperoxide Synthases / biosynthesis*
  • Pyridines / pharmacology
  • Rats
  • Serum Albumin, Bovine / immunology
  • Tumor Cells, Cultured
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Antigens
  • Dinitrophenols
  • Enzyme Inhibitors
  • Imidazoles
  • Isoenzymes
  • Lipoxygenase Inhibitors
  • Membrane Proteins
  • Pyridines
  • dinitrophenyl-bovine serum albumin
  • Serum Albumin, Bovine
  • Dexamethasone
  • Arachidonate 5-Lipoxygenase
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Ptgs1 protein, rat
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Phospholipases A
  • 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole